$Plug Power(PLUG)$   Plug Power continues to raise serious capital-structure and governance concerns that make the stock unsuitable for risk tolerance at this time. Key concerns 1. Explicit dilution risk - The company has announced a special shareholder vote to increase authorized shares, citing the need for financial flexibility.  This signals a high likelihood of future equity issuance, which would dilute existing shareholders. 2. Reverse split risk Management has stated that if shareholders do not approve the increase in authorized shares, the company may proceed with a reverse stock split. Historically, reverse splits are associated with weak balance sheets and poor post-split performance. 3. Insider co

$INCANNEX HEALTHCARE LTD(IXHL)$ 🔥🔥 IXHL – THIS IS WHY SMART MONEY IS STARTING TO PAY ATTENTION 🔥🔥 Incannex Healthcare is no longer just another “hope-and-pray” micro-biotech. Let’s get real 👇 🚀 $12.5M private placement COMPLETED → Cash secured → Overhang removed → Balance sheet strengthened → Company can now focus fully on execution 🏆 Clinical Trials Arena Excellence Award (2025) → External industry validation → NOT a press release fluff award → Confirms IHL-42X is being taken seriously 💊 Late-stage program targeting Obstructive Sleep Apnea (OSA) → Massive, multi-billion-dollar market → Oral alternative to CPAP = HUGE unmet demand → Real-world relevance, not niche science 📊 Price action tells the story Heavy volume (15–30M shares/day) Sharp spike

$Plug Power(PLUG)$   🚩 Negative take on the insider sale The recent share disposal by Benjamin Haycraft, CSO & GM EMEA of Plug Power, is badly timed and sends the wrong signal to the market. Why this looks bearish 1) Timing destroys confidence This sale comes right after: A confidence-damaging Walmart disclosure A sharp selloff and fragile rebound Heightened concerns over cash burn and dilution When senior executives sell during a credibility crisis, investors reasonably ask: “If the risk–reward is attractive here, why is management exiting?” 2) No offsetting insider buying There is no visible insider buying to counterbalance this sale. In stressed situations, markets look for symbolic confidence buys. Selli

$Plug Power(PLUG)$   🚩 Negative take on the insider sale The recent share disposal by Benjamin Haycraft, CSO & GM EMEA of Plug Power, is badly timed and sends the wrong signal to the market. Why this looks bearish 1) Timing destroys confidence This sale comes right after: A confidence-damaging Walmart disclosure A sharp selloff and fragile rebound Heightened concerns over cash burn and dilution When senior executives sell during a credibility crisis, investors reasonably ask: “If the risk–reward is attractive here, why is management exiting?” 2) No offsetting insider buying There is no visible insider buying to counterbalance this sale. In stressed situations, markets look for symbolic confidence buys. Selli

$Plug Power(PLUG)$  

$Plug Power(PLUG)$  

$Pony AI Inc(PONY)$   ⭐ Stock Review: Pony AI Inc (PONY) Pony AI is increasingly standing out as one of the most advanced and commercially focused players in the autonomous driving space. What differentiates Pony AI from many “concept-stage” AI companies is its clear transition from R&D to real-world monetisation. The company’s 7th-generation robotaxi fleet in Guangzhou has reportedly achieved positive unit economics, a key milestone that very few autonomous driving companies globally can claim today. From a business perspective, Pony AI is demonstrating: Strong revenue momentum, with meaningful year-on-year growth Improving gross margins, reflecting better cost control and operational efficiency A clear scaling roadmap, targeting thousan

$INCANNEX HEALTHCARE LTD(IXHL)$ ⭐ Investment Review: Incannex Healthcare (IXHL) Incannex Healthcare represents one of the more compelling asymmetric opportunities in the small-cap biotechnology space, particularly within the global obstructive sleep apnea (OSA) market — a condition that remains massively underserved despite affecting hundreds of millions worldwide. 🧠 A Clear, Focused Vision Unlike many early-stage biotechs that spread resources thin across multiple speculative programs, Incannex has demonstrated clear strategic focus. Its lead asset, IHL-42X, targets obstructive sleep apnea using an oral, fixed-dose combination therapy — a potential paradigm shift in a field currently dominated by mechanical solutions like CPAP, which suffer from

$Pony AI Inc(PONY)$   🚀 Pony AI Inc (PONY): A Next-Generation Autonomous Driving Leader Poised for Significant Growth Pony AI is quickly emerging as one of the most compelling innovators in the global autonomous driving industry. Backed by world-class technology, strong partnerships, and expanding commercial operations, the company is now transitioning from early-stage development to real-world deployment at scale — a shift that could unlock tremendous long-term value for investors. --- 🌟 1. Industry Leadership With Proven Technology Pony AI is one of the very few companies worldwide with: Fully driver-free (Level 4) robotaxi operations in major cities such as Beijing, Guangzhou, Shenzhen, and Shanghai. Over 30 million kilometers of autonomou

$Pony AI Inc(PONY)$   🚀 Pony.ai Inc. (PONY) – Driving the Future of Autonomous Mobility 🏁 Overview Pony.ai is emerging as one of the world’s most advanced and credible autonomous driving companies. Founded in 2016, the company has rapidly transitioned from research to real-world commercial operations — deploying robotaxi services across Beijing, Guangzhou, Shenzhen, and expanding into Singapore, Dubai, and Europe. With deep partnerships with Toyota, Uber, Tencent, and major Chinese OEMs, Pony.ai has positioned itself at the forefront of the global driverless revolution. --- ⚙️ Business Momentum & Achievements Gen-7 Robotaxi Breakthrough: The company’s Gen-7 platform has achieved a 70% reduction in production cost and integrates automotive

$Plug Power(PLUG)$  

$INCANNEX HEALTHCARE LTD(IXHL)$ If the IXHL discovered an oral cure for chronic obstructive sleep apnea (OSA), the impact would be enormous—medically, socially, and economically. Here’s how it might play out: 🌍 Medical Impact 1. End of CPAP dependency – Millions of patients would no longer need to use CPAP machines or other invasive devices every night. 2. Reduced surgeries – Procedures like UPPP (uvulopalatopharyngoplasty), jaw advancement, or hypoglossal nerve stimulation would see a huge decline. 3. Better overall health – Untreated OSA contributes to hypertension, heart disease, stroke, diabetes, and even dementia. A cure could lower risks across all of these. 4. Sleep quality revolution – Millions would finally get restorative sleep, re

$INCANNEX HEALTHCARE LTD(IXHL)$ 📊 Incannex Healthcare (IXHL) – Opportunity at Current Levels Incannex Healthcare (NASDAQ: IXHL) closed recently at $0.45, a level that coincides with key technical support. The company’s FY2025 results highlight both challenges and progress in its development path: Revenue: $0.086M (+617% YoY), primarily from expansion of rehabilitation services. Operating expenses: $23.9M (↓21% YoY), reflecting tighter cost control. R&D investment: $10.8M, demonstrating continued focus on advancing the pipeline. Net loss: $46.9M, consistent with heavy R&D activity as trials progress. Although IXHL has not yet generated material revenue from product sales, management is advancing late-stage clinical programs, including ther

$Nokia Oyj(NOK)$   Nokia (NYSE: NOK) has recently gained investor attention following a manager’s insider purchase disclosure (Uitto’s transaction under EU Market Abuse Regulation). Insider buying is generally interpreted as a strong vote of confidence from leadership, signaling that management views the stock as undervalued and poised for growth. 🔹 Financial Strength and Outlook Revenue Growth: Nokia reported €5.3B in Q2 2025 revenue, demonstrating resilience in its Networks and Cloud segments. While the telecom equipment sector remains competitive, Nokia’s cost optimization initiatives have preserved healthy margins. Profitability: Operating margin improved to 8.9%, reflecting disciplined execution despite macr

$Voyager Technologies, Inc.(VOYG)$   🚀 Voyager Technologies (NYSE: VOYG) — Positive Stock Outlook Voyager Technologies (VOYG), the Denver-based aerospace and defense technology company, is emerging as one of the most exciting new entrants in the public markets. Since its IPO in June 2025, Voyager has quickly positioned itself as a key player in commercial space infrastructure, defense systems, and the landmark Starlab space station project. 📊 Strong Market Debut IPO Price: $31.00 (June 11, 2025) Debut Performance: Stock surged +82% on first day, hitting highs of ~$74 before stabilizing in the $54–57 range. Current Price (Aug 21, 2025): $30.36 — offering investors a rare chance to enter well below its debut valuation. 📈 Growth Potential TTM Re

$Surf Air Mobility Inc.(SRFM)$   Made quick cash

$WeRide Inc.(WRD)$   🚨 Critical Review: WeRide’s Partnership with Grab WeRide’s much-touted partnership with Grab has been marketed as a breakthrough for autonomous mobility in Southeast Asia, but a closer look raises more red flags than opportunities. 1. Execution Risks in Emerging Markets Grab operates in markets with poor infrastructure, inconsistent regulations, and unpredictable traffic conditions. Rolling out autonomous vehicles in such environments will be far more complex than in the U.S. or China. The likelihood of operational delays, safety issues, and regulatory pushback is high. 2. Regulatory Uncertainty Unlike China or the U.S., Southeast Asia does not have a mature autonomous vehicle regulatory fram

$Grab Holdings(GRAB)$   Lastest news: https://sg.yahoo.com/news/grab-users-singapore-shocked-fares-061500247.html

$Palantir Technologies Inc.(PLTR)$   Palantir Technologies (PLTR) – A Transformative Growth Story Unfolding Palantir is no longer just a speculative data company—it is fast becoming one of the most mission-critical software providers for governments and enterprises worldwide. While critics point to high valuation multiples, the fundamentals tell a different story: sustained growth, strengthening profitability, and unmatched positioning in the AI revolution. 1. Profitability Has Arrived – and Is Expanding PLTR has now delivered six consecutive quarters of GAAP profitability—a milestone many doubted would ever come. In Q2 2025, operating margins hit 32%, showcasing disciplined execution. Free cash flow remains rob

$Pony AI Inc(PONY)$   Now it reached its peak for short term, time to sell off some and goes into others like Weride.